lumacaftor

Italy

Drugs containing this active substance

  • ORKAMBI

    It is used for the long-term treatment of cystic fibrosis in patients (aged 1 year and older) who have a specific genetic mutation called F508del.

    Form: tablets, film-coated

    Active substance Dosage
    ivacaftor -
    lumacaftor -

    ATC: R07AX30

    Manufacturer: VERTEX PHARMACEUTICALS (IRELAND) LIMITED